Pages that link to "Q38151562"

The following pages link to The genetic complexity of common cancers and the promise of personalized medicine: is there any hope? (Q38151562):

Displaying 18 items.

• ALK inhibitors in non-small cell lung cancer: the latest evidence and developments (Q26769879) (← links)
• Barriers to clinical adoption of next generation sequencing: Perspectives of a policy Delphi panel (Q28595689) (← links)
• Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types (Q34457638) (← links)
• Triggering necroptosis in cisplatin and IAP antagonist-resistant ovarian carcinoma. (Q34541689) (← links)
• Application of molecular profiling in clinical trials for advanced metastatic cancers (Q35102633) (← links)
• Rapid targeted somatic mutation analysis of solid tumors in routine clinical diagnostics (Q35798726) (← links)
• Circulating Cell-Free Tumour DNA in the Management of Cancer (Q35814162) (← links)
• Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric andTeen Patients Allows Identifying Two Main Classes of Biological ProcessesInvolved and New Potential Therapeutic Targets (Q36658489) (← links)
• Other side of the coin for personalised medicine and healthcare: content analysis of 'personalised' practices in the literature (Q37100793) (← links)
• Integrating precision cancer medicine into healthcare-policy, practice, and research challenges (Q37360550) (← links)
• Pilot Trial of Selecting Molecularly Guided Therapy for Patients with Non-V600 BRAF-Mutant Metastatic Melanoma: Experience of the SU2C/MRA Melanoma Dream Team. (Q38524536) (← links)
• Can kinomics and proteomics bridge the gap between pediatric cancers and newly designed kinase inhibitors? (Q38969204) (← links)
• Barriers to clinical adoption of next-generation sequencing: a policy Delphi panel's solutions. (Q45951369) (← links)
• Pathology in drug discovery and development (Q48615889) (← links)
• Diagnostic yield of a biopsy performed immediately after lung radiofrequency ablation. (Q53084428) (← links)
• Seeking the driver in tumours with apparent normal molecular profile on comparative genomic hybridization and targeted gene panel sequencing: what is the added value of whole exome sequencing? (Q53267051) (← links)
• Progress towards personalized medicine for ameloblastoma. (Q54358697) (← links)
• A patient-derived explant (PDE) model of hormone-dependent cancer (Q58772979) (← links)